Pulkoski-Gross et al. (2015) found that trifluoperazine notably decreased angiogenesis, reduced VEGF expression, and inhibited cancer cell invasion by lowering phosphorylated AKT and β-catenin levels (90). Here, AKT1 is linked to cancer.